Welcome! To our new Beyond Type 1 and Beyond Type 2 website! Hear from the team about the change.

Is the Rising Use of Cannabis Among U.S. Adults with Diabetes a Health Concern?

Written by: Daniel Trecroci

2 minute read

July 24, 2024

According to a recent study published in the July 22, 2024 issue of Diabetes Care, the percentage of adult Americans with diabetes who use cannabis increased by 33.7% between 2021 and 2022.

The findings highlight the necessity of more thorough screening and informational campaigns about the possible dangers of cannabis use for this susceptible group.

A study by researchers at the University of California San Diego School of Medicine found that 33.7% more people with diabetes in 2022—or about 9% of adults with diabetes—reported smoking cannabis in the previous month.

The findings are based on data from the 2021-2022 National Survey on Drug Use and Health, encompassing 6,816 adults diagnosed with diabetes.

The United States has seen an increase in cannabis use as more states have legalized the drug for both medical and recreational use. Despite potential risks such as diabetic ketoacidosis and adverse effects on metabolic factors, comprehensive research on these impacts remains sparse.

The study highlights the need for healthcare professionals to proactively discuss the possible risks of cannabis usage and other psychoactive substances with individuals who have diabetes.

The following factors were also connected to an increased incidence of cannabis usage in people with diabetes:

  • Residents of places where cannabis is legal
  • A history of hepatitis
  • Recent major depressive episodes, and
  • Concurrent use of alcohol or opioids.

However, limitations in the study—including the inability to distinguish between types of diabetes or cannabis products used—underscore the need for further research. The authors emphasize how critical it is to address these gaps in order to give clinicians treating patients with diabetes more precise instructions.

“Clinicians must weigh the potential benefits against the risks when discussing cannabis use with diabetic patients, ensuring informed decision-making and comprehensive management of their health.”

Editor’s Note: Beyond Type 1 in no way encourages illegal activity. Marijuana possession and usage continue to be offenses under United States federal law and in many countries. Content contained within this article is meant for informational purposes. 

Author

Daniel Trecroci

Dan has written about diabetes for more than 20 years. He was one of Diabetes Health's first recruits, and throughout his 10 + years as Managing Editor he wrote/published thousands of articles and helped establish Diabetes Health as the premiere resource for people with diabetes. He later became the Content Manager for OneTouchGold—Johnson & Johnson/LifeScan’s official digital publication for its metering-technology customers. Under his leadership, OneTouchGold received the Web Marketing Association’s award for “Best Health & Wellness" web site. Dan has also written for the Diabetes Research Institute, dLife, diaTribe, Healthline, CareDx, Pendulum Therapeutics, and Hero Bread.